Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Gene

• Publication date

  2014-03-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.gene.2013.11.081PMID 24325907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gut metagenome in European women with normal, impaired and diabetic glucose control

  2013cited by this paper
• Abundance and Diversity of Microbiota in Type 2 Diabetes and Obesity

  2013influential reference
• Short chain fatty acids and their receptors: new metabolic targets.

  2013cited by this paper
• Effects of antibiotic therapy on the gastrointestinal microbiota and the influence of Lactobacillus casei

  2013cited by this paper
• GPR41 Gene Expression Is Mediated by Internal Ribosome Entry Site (IRES)-dependent Translation of Bicistronic mRNA Encoding GPR40 and GPR41 Proteins*

  2012cited by this paper
• The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus

  2012cited by this paper
• Butyrate-induced GPR41 activation inhibits histone acetylation and cell growth.

  2012cited by this paper
• Functional interactions between the gut microbiota and host metabolism

  2012cited by this paper
• LINE-1 methylation in visceral adipose tissue of severely obese individuals is associated with metabolic syndrome status and related phenotypes

  2012cited by this paper
• Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms

  2012influential reference
• Leaky gut and diabetes mellitus: what is the link?

  2011cited by this paper
• Peptide hormones regulating appetite—focus on neuroimaging studies in humans

  2011cited by this paper
• Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma

  2011cited by this paper
• Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases.

  2011cited by this paper
• Do nutrient–gut–microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?

  2011cited by this paper
• Quantification of butyryl CoA:acetate CoA-transferase genes reveals different butyrate production capacity in individuals according to diet and age.

  2011cited by this paper
• Intestinal microbiota in human health and disease: the impact of probiotics

  2011cited by this paper
• Interaction between obesity and the gut microbiota: relevance in nutrition.

  2011cited by this paper
• Epigenetic mechanisms elicited by nutrition in early life

  2011cited by this paper
• Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults

  2010influential reference
• A human gut microbial gene catalogue established by metagenomic sequencing

  2010cited by this paper
• Executive Summary: Standards of Medical Care in Diabetes—2010

  2010cited by this paper
• The environment within: how gut microbiota may influence metabolism and body composition

  2010influential reference
• Standards of Medical Care in Diabetes—2010

  2010cited by this paper
• Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss

  2010cited by this paper
• Molecular Characterisation of the Faecal Microbiota in Patients with Type II Diabetes

  2010influential reference
• Microbiota and SCFA in Lean and Overweight Healthy Subjects

  2010influential reference
• Repetitive element DNA methylation and circulating endothelial and inflammation markers in the VA normative aging study

  2010cited by this paper
• Obesity, Diabetes, and Gut Microbiota

  2010cited by this paper
• Lipid receptors and islet function: therapeutic implications?

  2009cited by this paper
• Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice

  2009cited by this paper
• Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine.

  2009influential reference
• The core gut microbiome, energy balance and obesity

  2009cited by this paper
• Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis.

  2009cited by this paper
• Translational research into gut microbiota: new horizons in obesity treatment.

  2009cited by this paper
• Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

  2008cited by this paper
• Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41

  2008cited by this paper
• Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice

  2008cited by this paper
• Human colonic microbiota associated with diet, obesity and weight loss

  2008cited by this paper
• Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes

  2008cited by this paper
• Review article: the role of butyrate on colonic function

  2007influential reference
• Development of a Semiquantitative Degenerate Real-Time PCR-Based Assay for Estimation of Numbers of Butyryl-Coenzyme A (CoA) CoA Transferase Genes in Complex Bacterial Samples

  2007cited by this paper
• Reduced Dietary Intake of Carbohydrates by Obese Subjects Results in Decreased Concentrations of Butyrate and Butyrate-Producing Bacteria in Feces

  2006cited by this paper
• An obesity-associated gut microbiome with increased capacity for energy harvest

  2006influential reference
• Control of gene expression by fatty acids.

  2004cited by this paper
• The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids*

  2003influential reference
• Regulation of short-chain fatty acid production

  2003cited by this paper
• Concomitant changes in polyamine pools and DNA methylation during growth inhibition of human colonic cancer cells.

  1998cited by this paper
• Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA

  1993cited by this paper
• Compilation of small ribosomal subunit RNA sequences.

  1992cited by this paper
• Compilation of small ribosomal subunit RNA sequences.

  1991cited by this paper
• Energy contributions of volatile fatty acids from the gastrointestinal tract in various species.

  1990cited by this paper

• Targeted serum metabolomics reveals novel metabolic associations between fatty acid and kynurenine metabolism in nonalcoholic fatty liver

  2026cites this paper
• Exploring the mechanism of action of Rosa roxburghii Tratt quercetin in ameliorating type 2 diabetes in mice based on the intestinal microbiome and metabolomics

  2025cites this paper
• Implication of Gut Mycobiome and Virome in Type-2 Diabetes Mellitus: Uncovering the Hidden Players

  2025cites this paper
• What Is the Involvement of Gut Microbiome in the Pathophysiology of Diabetes?

  2025cites this paper
• Effects of GLP-1 Analogues and Agonists on the Gut Microbiota: A Systematic Review

  2025cites this paper
• Exploring the Link Between the Gut Microbiota and Epigenetic Factors in Anorexia Nervosa

  2025cites this paper
• Live bacteria in gut microbiome dictate asthma onset triggered by environmental particles via modulation of DNA methylation in dendritic cells

  2025cites this paper
• In Search of Healthy Ageing: A Microbiome-Based Precision Nutrition Approach for Type 2 Diabetes Prevention

  2025cites this paper
• Mechanisms of gut microbiota in host fat deposition: metabolites, signaling pathways, and translational applications

  2025cites this paper
• The hologenome in brain health and disease.

  2025cites this paper
• Puerarin Regulates Gut Homeostasis in T2DM Rats Involving Structural and Functional Alterations of Gut Microbiota and Paneth Cell Function.

  2025cites this paper
• Methylation of LINE-1 Retroelement in People with Type 1 Diabetes

  2025cites this paper
• Microbiota-derived metabolites in the epigenetic regulation of the host.

  2025cites this paper
• Targeted Therapy for Gut Microbiota: Candidates for a Novel Strategy to Ameliorate Type 2 Diabetes Mellitus

  2025cites this paper
• DNA methylation and non-coding RNAs in metabolic disorders: Epigenetic Roles of Nutrients, Dietary Patterns and Weight Loss Interventions for Precision Nutrition.

  2024cites this paper
• Retrotransposons and Diabetes Mellitus

  2024cites this paper
• The Gut Microbial Regulation of Epigenetic Modification from a Metabolic Perspective

  2024influential citation
• Sodium Butyrate, a Gut Microbiota Derived Metabolite, in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Review.

  2024cites this paper
• Bioactive compounds of foods: Phytochemicals and peptides

  2024cites this paper
• Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations

  2024cites this paper
• Obesity-associated microbiomes instigate visceral adipose tissue inflammation by recruitment of distinct neutrophils

  2024cites this paper
• Expression of PGC-1α, PPAR-α and UCP1 genes, metabolic and anthropometric factors in response to sodium butyrate supplementation in patients with obesity: a triple-blind, randomized placebo-controlled clinical trial

  2024cites this paper
• A Comprehensive Review on Weight Gain following Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists for Obesity

  2024cites this paper
• Interactions between the gut microbiome and DNA methylation patterns in blood and visceral adipose tissue in subjects with different metabolic characteristics

  2024cites this paper
• Fatty acids and epigenetics in health and diseases

  2024cites this paper
• Bioactive Compounds and Their Chondroprotective Effects for Osteoarthritis Amelioration: A Focus on Nanotherapeutic Strategies, Epigenetic Modifications, and Gut Microbiota

  2024cites this paper
• Investigation of the hypoglycemic mechanism of the ShenQi compound formula through metabonomics and 16S rRNA sequencing

  2024cites this paper
• Association of Gut Microbiota with the Incidence of Metabolic Syndrome among Type 2 Diabetes Mellitus Patients

  2024cites this paper
• SCFAs Supplementation Rescues Anxiety- and Depression-like Phenotypes Generated by Fecal Engraftment of Treatment-Resistant Depression Rats.

  2024cites this paper
• RNA expression changes driven by altered epigenetics status related to NASH etiology.

  2024cites this paper
• Deciphering the complex interplay of risk factors in type 2 diabetes mellitus: A comprehensive review

  2024cites this paper
• The Interplay between Mycobacterium tuberculosis and Human Microbiome

  2024cites this paper
• Nutritional Interventions, Probiotics, Synbiotics and Fecal Microbiota Transplantation in Steatotic Liver Disease : Pediatric Fatty Liver and Probiotics.

  2024cites this paper
• miR‐34a/SIRT1/HIF‐1α axis is involved in cardiac angiogenesis of type 2 diabetic rats: The protective effect of sodium butyrate combined with treadmill exercise

  2023cites this paper
• The Role of PPARγ Gene Polymorphisms, Gut Microbiota in Type 2 Diabetes: Current Progress and Future Prospects

  2023cites this paper
• Gut microbiota profiles in two New Zealand cohorts with overweight and prediabetes: a Tū Ora/PREVIEW comparative study

  2023cites this paper
• Positive Regulation of Acetate in Adipocyte Differentiation and Lipid Deposition in Obese Mice

  2023cites this paper
• Gut microbiota dysbiosis-associated obesity and its involvement in cardiovascular diseases and type 2 diabetes. A systematic review.

  2023cites this paper
• E ff ect of a 12 ‐ Week Polyphenol Rutin Intervention on Markers of Pancreatic β‐ Cell Function and Gut Microbiota in Adults with Overweight without Diabetes

  2023cites this paper
• Probiotics supplementation for management of type II diabetes risk factors in adults with polycystic ovarian syndrome: a meta-analysis of randomized clinical trial

  2023cites this paper
• Akkermansia muciniphila supplementation improves glucose tolerance in intestinal Ffar4 knockout mice during the daily light to dark transition

  2023cites this paper
• Effect of Benaglutide on Gut Microbiota and Fecal Metabolites in Patients with Type 2 Diabetes Mellitus

  2023cites this paper
• Effect of a 12-Week Polyphenol Rutin Intervention on Markers of Pancreatic β-Cell Function and Gut Microbiota in Adults with Overweight without Diabetes

  2023cites this paper
• Hypoglycemic Effect of Trichosanthes Pericarpium to Type 2 Model Diabetic Mice via Intestinal Bacteria Transplantation.

  2023cites this paper
• Gut Microbiota, LADA, and Type 1 Diabetes Mellitus: An Evolving Relationship

  2023cites this paper
• Immunomagnetic Capture of Faecalibacterium prausnitzii Selectively Modifies the Fecal Microbiota and Its Immunomodulatory Profile

  2023cites this paper
• The Implication of Short-Chain Fatty Acids in Obesity and Diabetes

  2023influential citation
• Complete genome analysis of Bacillus subtilis derived from yaks and its probiotic characteristics

  2023cites this paper
• The Intestinal Microbiota and Short-Chain Fatty Acids in Association with Advanced Metrics of Glycemia and Adiposity Among Young Adults with Type 1 Diabetes and Overweight or Obesity

  2022cites this paper
• An Improved Method to Quantify Short-Chain Fatty Acids in Biological Samples Using Gas Chromatography–Mass Spectrometry

  2022cites this paper
• Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics.

  2022cites this paper
• The impact of dietary, surgical, and pharmacological interventions on gut microbiota in individuals with diabetes mellitus: a systematic review.

  2022cites this paper
• Associations of Dietary Intake with the Intestinal Microbiota and Short-Chain Fatty Acids Among Young Adults with Type 1 Diabetes and Overweight or Obesity.

  2022cites this paper
• Nanocellulose as a Functional Ingredient in the Management of Metabolic Syndrome: A Review

  2022cites this paper
• Insights on the role of anti-inflammatory and immunosuppressive agents in the amelioration of diabetes

  2022cites this paper
• Changes in gut microbiota, metabolite SCFAs, and GPR43 expression in obese diabetic mice after sleeve gastrectomy

  2022cites this paper
• Arabinogalactan, Bifidobacterium longum , and Faecalibacterium prausnitzii improve insulin resistance in high‐fat diet‐induced C57BL/6J mice

  2022cites this paper
• Role of microbiome and its metabolite, short chain fatty acid in prostate cancer

  2022cites this paper
• Epigenetic regulation by metabolites from the gut microbiome.

  2022cites this paper
• Interactions between Dietary Micronutrients, Composition of the Microbiome and Efficacy of Immunotherapy in Cancer Patients

  2022cites this paper
• Elucidation of the initial bacterial community of Ezine PDO cheese using next-generation sequencing

  2022cites this paper
• Associations of disordered eating with the intestinal microbiota and short-chain fatty acids among young adults with type 1 diabetes.

  2022cites this paper
• The next generation beneficial actions of novel probiotics as potential therapeutic targets and prediction tool for metabolic diseases

  2022cites this paper
• Short-Chain Fatty Acid Receptors and Cardiovascular Function

  2022cites this paper
• Two Blautia Species Associated with Visceral Fat Accumulation: A One-Year Longitudinal Study

  2022cites this paper
• Novel epigenetic therapeutic strategies and targets in cancer.

  2022cites this paper
• Epigenetic Links between Microbiota and Gestational Diabetes

  2022cites this paper
• Gut Microbiota Composition in Prediabetes and Newly Diagnosed Type 2 Diabetes: A Systematic Review of Observational Studies

  2022cites this paper
• Environmental microplastics exposure decreases antioxidant ability, perturbs gut microbial homeostasis and metabolism in chicken.

  2022cites this paper
• Butyrate to combat obesity and obesity‐associated metabolic disorders: Current status and future implications for therapeutic use

  2022cites this paper
• Paternal transgenerational nutritional epigenetic effect: A new insight into nutritional manipulation to reduce the use of antibiotics in animal feeding

  2022cites this paper
• Role of the Microbiome in the Pathogenesis of COVID-19

  2022cites this paper
• Genetic and Epigenetic Regulation by Gut Microbe-Modulated Metabolites in Chronic Metabolic Diseases

  2022cites this paper
• Synbiotics and Gut Microbiota: New Perspectives in the Treatment of Type 2 Diabetes Mellitus

  2022cites this paper
• Gut microbiota induces DNA methylation via SCFAs predisposing obesity-prone individuals to diabetes.

  2022cites this paper
• Bariatric Surgery

  2022cites this paper
• The role of nutrition in inflammaging.

  2022cites this paper
• Shenqi compound ameliorates type-2 diabetes mellitus by modulating the gut microbiota and metabolites.

  2022cites this paper
• Short-chain fatty acids: possible regulators of insulin secretion

  2022cites this paper
• Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS.

  2022cites this paper
• The Compositional Structure of the Small Intestinal Microbial Community via Balloon-Assisted Enteroscopy

  2022cites this paper
• Epigenetic Regulation of Obesity-Associated Type 2 Diabetes

  2022cites this paper
• Host-epigenetics-microbiota: A tripartite interaction in health and disease

  2021cites this paper
• The Role of Microbiota in the Development of Cancer Tumour Cells and Lymphoma of B and T Cells

  2021cites this paper
• Repression of HDAC5 by acetate restores hypothalamic-pituitary-ovarian function in type 2 diabetes mellitus.

  2021cites this paper
• Polysaccharides on the gut microbiome and epigenome

  2021cites this paper
• Resveratrol as Anti-Obesity and Anticancer Agent

  2021cites this paper
• Gut microbiota and hypertension, diabetes, and other cardiovascular risk factors

  2021cites this paper
• Effect of Diet and Dietary Components on the Composition of the Gut Microbiota

  2021cites this paper
• Discovering Potential Taxonomic Biomarkers of Type 2 Diabetes From Human Gut Microbiota via Different Feature Selection Methods

  2021cites this paper
• The interaction among gut microbes, the intestinal barrier and short chain fatty acids

  2021cites this paper
• Contribution of microbiota in obesity and obesity-related chronic diseases

  2021cites this paper
• Long‐term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children

  2021cites this paper
• Dissecting the Interplay Mechanism between Epigenetics and Gut Microbiota: Health Maintenance and Disease Prevention

  2021cites this paper
• Intraperitoneal Administration of Short-Chain Fatty Acids Improves Lipid Metabolism of Long–Evans Rats in a Sex-Specific Manner

  2021cites this paper
• The link among microbiota, epigenetics, and disease development

  2021cites this paper
• Rescue effect of sodium acetate in diabetes mellitus-associated testicular dysfunction is accompanied by PCSK9 modulation.

  2021cites this paper
• Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes

  2021cites this paper
• The efficacy and toxicity of antineoplastic antimetabolites: role of gut microbiota.

  2021cites this paper
• A comprehensive review for gut microbes: technologies, interventions, metabolites and diseases.

  2021cites this paper